REGN

Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
$614.78
-6.74 (-1.08%)
Mkt Cap: 63.34B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield5.1%
Dividend YieldN/A
Market Cap63.34B
Volume1.84M
Recent News
Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound?
zacks.com · 2026-05-29
Regeneron's Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
globenewswire.com · 2026-05-28
These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth
247wallst.com · 2026-05-28
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
prnewswire.com · 2026-05-28
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
globenewswire.com · 2026-05-26
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Regeneron Pharmaceuticals, Inc. (REGN)
newsfilecorp.com · 2026-05-25

Unlock the Full Deep Scan

9 AI agents analyze REGN across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →